Sponsor content
850 result(s) found, displaying 441 to 450
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALICIP lenalidomide 25 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIMID lenalidomide 20 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIMID lenalidomide 5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALICIP lenalidomide 10 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALICIP lenalidomide 15 mg capsule blister pack.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021